Hyderabad-based Shantha Biotechnics has bagged a $340 million (around Rs 1,650 crore) order from Unicef to supply its 'SHAN5', a combination of five vaccines.
Despite the best efforts of Indian vaccine makers to develop the H1N1(swine flu) vaccine, Swiss drug major Novartis and Australian vaccine maker CSL may be the first ones to bag the orders from the central government for its supply.
In another indication of Big Pharma’s growing interest in India’s drug manufacturing capabilities, French drug multinational Sanofi Aventis has announced plans to acquire Merieux Alliance’s majority stake in Hyderabad-based vaccine firm Shantha Biotechnics.
The Indraprastha Apollo Hospital in New Delhi has a surprise for its youngest "guests". Anoothi Vishal checks out a first-of-its-kind "recreation centre" set up by Sanofi Aventis there.
The National Pharmaceutical Pricing Authority (NPPA) has decided to revise the prices of over 200 life-saving medicines of wide-ranging therapeutic categories.
In yet another instance of a patent fight between an Indian pharma company and a global giant, Europes biggest drug firm Sanofi Aventis has threatened to sue Pune-based Emcure if the latter exports
Sanofi Aventis and Bristol-Myers Squibb have offered an out-of court-settlement to Hyderabad-based Dr Reddys Laboratories for their $6 billion-a-year drug Plavix.
Sanofi Aventis and Bristol-Myers Squibb have offered an out-of court-settlement to Hyderabad-based Dr Reddys Laboratories for their $6 billion-a-year drug Plavix.
It has been a major turn around for the domestic pharmaceuticals companies, which posted huge losses in the last quarter of the last financial year due to the uncertainity over the implementation of
Content Guide
